Showing results (101-110 of 282) with videos related to

Sort By:
Pageof 29
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaWei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
The American Journal of Surgical Pathology|March 30, 2018
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F MutationsHatice D Gur, Sanam Loghavi, Guillermo Garcia-Manero, et al.
British Journal of Haematology|January 17, 2007
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemiaFrancis J Giles, Gautam Borthakur, Farhad Ravandi, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2014
Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: an emerging entity with a poor prognosisElias Jabbour, Hady Ghanem, Xuelin Huang, et al.
American Journal of Hematology|January 25, 2014
Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromesNaval Daver, Kiran Naqvi, Elias Jabbour, et al.
Blood|July 20, 2002
Myelodysplastic syndrome is not merely "preleukemia"Maher Albitar, Taghi Manshouri, Yu Shen, et al.
Cancer|April 28, 2006
Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutionsBassem I Razzouk, Elihu Estey, Stanley Pounds, et al.
Blood|October 7, 2010
Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapyFarhad Ravandi, Jorge Cortes, Stefan Faderl, et al.
British Journal of Haematology|March 28, 2013
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITDKoichi Takahashi, Hagop Kantarjian, Naveen Pemmaraju, et al.
The Lancet. Haematology|December 22, 2015
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trialsKoji Sasaki, Sara S Strom, Susan O'Brien, et al.
Pageof 29